Healthcare & Medical Devices Global On demand · 24-48h

Global Allergy Diagnostic Service Market Strategic Research Report

Global Allergy Diagnostic Service Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Allergy Diagnostic Service Market
$8.71B2025
3.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Blood Tests, Skin-prick Tests, Food Challenge Tests, Others

By Application: Clinical Diagnosis, Health Screening

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific Inc, Siemens Healthcare GmbH, Allergy Diagnostics, EUROIMMUN Medizinische Labordiagnostika AG, Labcorp, Wycoff Wellness, GMC Medical Center, Bausch & Lomb Incorporated, Personal Physician Care, DST Diagnostische Systeme & Technologien GmbH, Foothills ENT, Quest Diagnostics Incorporated, Latitude, P.H.Diagnostic Centre, CADUCEUS MEDICAL GROUP, Vanguard Medical Group, P.A., Dia Lab Services Srl

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 127 pages
Market size 2025
$8.71B
Billion USD
Forecast CAGR
3.7%
2025-2032
Forecast 2032
$11.2B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Allergy Diagnostic Service market size is predicted to grow from US$ 8,706 million in 2025 to US$ 11,063 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032.

Allergy diagnostic services refer to medical testing services that identify and evaluate allergic sensitization and specific allergens using techniques such as in vitro immunoassays (e.g., specific IgE testing), in vivo skin tests, and component-resolved diagnostics. These services are widely used in the diagnosis and management of allergic rhinitis, asthma, food allergies, and allergic skin diseases.

From a global perspective, demand for allergy diagnostic services continues to grow, driven by the rising prevalence of allergic diseases, urbanization, environmental changes, and increased health awareness. North America and Europe are mature markets with a high level of testing standardization and increasing adoption of component-resolved diagnostics, while the Asia-Pacific region shows the fastest growth, supported by expanding testing populations, the development of independent diagnostic laboratories, and the rapid establishment of hospital allergy specialties, resulting in a market characterized by parallel trends of higher diagnostic precision and service scalability.

This report presents a comprehensive overview of the global Allergy Diagnostic Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Blood Tests
  • Skin-prick Tests
  • Food Challenge Tests
  • Others

Segment by Testing Resolution

  • In Vitro Immunoassay
  • In Vivo Skin Testing

Segment by Application

  • Clinical Diagnosis
  • Health Screening

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Allergy Diagnostic Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Clinical Diagnosis, Health Screening evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Allergy Diagnostic Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$8.71B
2025
Forecast
$11.2B
2032
CAGR
3.7%
2025–2032
Regiões
5
global
Key companies
Thermo Fisher Scientific IncSiemens Healthcare GmbHAllergy DiagnosticsEUROIMMUN Medizinische Labordiagnostika AGLabcorpWycoff WellnessGMC Medical CenterBausch & Lomb Incorporated
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Blood TestsSkin-prick TestsFood Challenge TestsOthers
By Application
Clinical DiagnosisHealth Screening

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Blood Tests
  • 3.1.3 Skin-prick Tests
  • 3.1.4 Food Challenge Tests
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Clinical Diagnosis
  • 4.1.3 Health Screening
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific Inc
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Siemens Healthcare GmbH
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Allergy Diagnostics
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 EUROIMMUN Medizinische Labordiagnostika AG
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Labcorp
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Wycoff Wellness
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 GMC Medical Center
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Bausch & Lomb Incorporated
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Personal Physician Care
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 DST Diagnostische Systeme & Technologien GmbH
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Foothills ENT
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Quest Diagnostics Incorporated
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Latitude
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 P.H.Diagnostic Centre
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 CADUCEUS MEDICAL GROUP
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Vanguard Medical Group, P.A.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Dia Lab Services Srl
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Allergy Diagnostic Service market?
The global Allergy Diagnostic Service market is estimated at US$ 8.71 billion in 2025 (base year) and is projected to reach US$ 11.06 billion by 2032.
What is the forecast CAGR for the Allergy Diagnostic Service market?
The market is expected to grow at a CAGR of 3.7% from 2026 to 2032, expanding from US$ 8.71 billion in 2025 to US$ 11.06 billion in 2032, roughly 1.3 times its base-year value.
What is Allergy Diagnostic Service?
Allergy diagnostic services refer to medical testing services that identify and evaluate allergic sensitization and specific allergens using techniques such as in vitro immunoassays (e.g., specific IgE testing), in vivo skin tests, and component-resolved diagnostics. These services are widely used in the diagnosis and management of allergic rhinitis, asthma, food allergies, and allergic skin diseases.
What are the main segments of the Allergy Diagnostic Service market by type?
By type, the market is segmented into Blood Tests, Skin-prick Tests, Food Challenge Tests and Others.
Which applications drive demand in the Allergy Diagnostic Service market?
Key applications covered include Clinical Diagnosis and Health Screening.
Who are the key players in the Allergy Diagnostic Service market?
Key players profiled include Thermo Fisher Scientific Inc, Siemens Healthcare GmbH, Allergy Diagnostics, EUROIMMUN Medizinische Labordiagnostika AG, Labcorp, Wycoff Wellness, GMC Medical Center and Bausch & Lomb Incorporated, among 17 companies covered in total.
Which regions and countries are covered for Allergy Diagnostic Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Allergy Diagnostic Service market?
From a global perspective, demand for allergy diagnostic services continues to grow, driven by the rising prevalence of allergic diseases, urbanization, environmental changes, and increased health awareness.
Who should buy the Allergy Diagnostic Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Clinical Diagnosis and Health Screening, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Allergy Diagnostic Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.